Targeting of lysosomes by liposomes modified with octadecyl-rhodamine B

Journal of Drug Targeting

Volumn 19, Issue 8, 2011, Pages 606-614

  Koshkaryev, Alexander ^a   Thekkedath, Ritesh ^a   Pagano, Cinzia ^b   Meerovich, Igor ^a   Torchilin, Vladimir P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Enzyme replacement therapy; Liposomes; Lysosomal targeting; Rhodamine B

Indexed keywords

5 DODECANOYLAMINOFLUORESCEIN DI BETA DEXTRO GALACTOPYRANOSIDE; BETA GALACTOSIDASE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; LIPOSOME; OCTADECYL RHODAMINE B; PYRANOSIDE; RHODAMINE B; UNCLASSIFIED DRUG;

ARTICLE; CELL FRACTIONATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; HYDRATION; LYSOSOME; PRIORITY JOURNAL;

CELL CULTURE TECHNIQUES; CULTURE MEDIA; DEXTRANS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCEINS; GALACTOSIDES; HELA CELLS; HUMANS; LIPIDS; LIPOSOMES; LYSOSOMES; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; PARTICLE SIZE; RHODAMINES; SURFACE PROPERTIES;

EID: 80051718862     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2010.550921     Document Type: Article

References (28)

1. Berth G, Voigt A, Dautzenberg H, Donath E, Möhwald H. (2002). Polyelectrolyte complexes and layer-by-layer capsules from chitosan/chitosan sulfate. Biomacromolecules, 3, 579-590. (Pubitemid 34567463)
2. Boddapati SV, D'Souza GG, Erdogan S, Torchilin VP, Weissig V. (2008). Organelle-targeted nanocarriers: specifc delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo. Nano Lett, 8, 2559-2563.
3. Boya P, Andreau K, Poncet D, Zamzami N, Perfettini JL, Metivier D, Ojcius DM, Jäättelä M, Kroemer G. (2003). Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med, 197, 1323-1334. (Pubitemid 36617779)
4. Futerman AH, van Meer G. (2004). Te cell biology of lysosomal storage disorders. Nat Rev Mol Cell Biol, 5, 554-565. (Pubitemid 38868584)
5. Grabowski GA. (2008). Phenotype, diagnosis, and treatment of Gaucher's disease. Lancet, 372, 1263-1271.
6. Grabowski GA, Hopkin RJ. (2003). Enzyme therapy for lysosomal storage disease: principles, practice, and prospects. Annu Rev Genomics Hum Genet, 4, 403-436. (Pubitemid 37392929)
7. Gregoriadis G. (1978). Liposomes in the therapy of lysosomal storage diseases. Nature, 275, 695-696.
8. Hoekstra D, de Boer T, Klappe K, Wilschut J. (1984). Fluorescence method for measuring the kinetics of fusion between biological membranes. Biochemistry, 23, 5675-5681. (Pubitemid 15189719)
9. Huth U, Wieschollek A, Garini Y, Schubert R, Peschka-Süss R. (2004). Fourier transformed spectral bio-imaging for studying the intracellular fate of liposomes. Cytometry A, 57, 10-21. (Pubitemid 38055710)
10. Huth US, Schubert R, Peschka-Süss R. (2006). Investigating the uptake and intracellular fate of pH-sensitive liposomes by fow cytometry and spectral bio-imaging. J Control Release, 110, 490-504. (Pubitemid 43168188)
11. Kirkegaard T, Jäättelä M. (2009). Lysosomal involvement in cell death and cancer. Biochim Biophys Acta, 1793, 746-754.
12. Kiss AL, Botos E. (2009). Endocytosis via caveolae: alternative pathway with distinct cellular compartments to avoid lysosomal degradation? J Cell Mol Med, 13, 1228-1237.
13. Ko YT, Kale A, Hartner WC, Papahadjopoulos-Sternberg B, Torchilin VP. (2009). Self-assembling micelle-like nanoparticles based on phospholipid- polyethyleneimine conjugates for systemic gene delivery. J Control Release, 133, 132-138.
14. Kuwana T, Mullock BM, Luzio JP. (1995). Identifcation of a lysosomal protein causing lipid transfer, using a fuorescence assay designed to monitor membrane fusion between rat liver endosomes and lysosomes. Biochem J, 308 (Pt 3), 937-946.
15. Luzio JP, Pryor PR, Bright NA. (2007). Lysosomes: fusion and function. Nat Rev Mol Cell Biol, 8, 622-632. (Pubitemid 47106614)
16. Mousavi SA, Malerød L, Berg T, Kjeken R. (2004). Clathrin-dependent endocytosis. Biochem J, 377, 1-16. (Pubitemid 38114427)
17. Pelkmans L, Kartenbeck J, Helenius A. (2001). Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol, 3, 473-483. (Pubitemid 32422083)
18. Plovins A, Alvarez AM, Ibañez M, Molina M, Nombela C. (1994). Use of fuorescein-di-beta-d-galactopyranoside (FDG) and C12-FDG as substrates for beta-galactosidase detection by fow cytometry in animal, bacterial, and yeast cells. Appl Environ Microbiol, 60, 4638-4641. (Pubitemid 24370848)
19. Rotman B, Zderic JA, Edelstein M. (1963). Fluorogenic substrates for beta-d-galactosidases and phosphatases derived from furescein (3,6-dihydroxyfuoran) and its monomethylether. Proc Natl Acad Sci USA, 50, 1-6.
20. Swanson JA. (2008). Shaping cups into phagosomes and macropinosomes. Nat Rev Mol Cell Biol, 9, 639-649.
21. Torball N. (1981). FITC-dextran tracers in microcirculatory and permeability studies using combined fuorescence stereo microscopy, fuorescence light microscopy and electron microscopy. Histochemistry, 71, 209-233.
22. Torchilin VP. (2006). Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng, 8, 343-375. (Pubitemid 44314821)
23. Torchilin VP. (2008). Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Adv Drug Deliv Rev, 60, 548-558. (Pubitemid 351215572)
24. Torchilin VP, Rammohan R, Weissig V, Levchenko TS. (2001). TAT peptide on the surface of liposomes afords their efcient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci USA, 98, 8786-8791. (Pubitemid 32678105)
25. van der Ploeg AT, Reuser AJ. (2008). Pompe's disease. Lancet, 372, 1342-1353.
26. Vult von Steyern F, Josefsson JO, Tågerud S. (1996). Rhodamine B, a fuorescent probe for acidic organelles in denervated skeletal muscle. J Histochem Cytochem, 44, 267-274. (Pubitemid 26081127)
27. Zarate YA, Hopkin RJ. (2008). Fabry's disease. Lancet, 372, 1427-1435.
28. Zhang W, Tang B, Liu X, Liu Y, Xu K, Ma J, Tong L, Yang G. (2009). A highly sensitive acidic pH fuorescent probe and its application to HepG2 cells. Analyst, 134, 367-371.